Pharmacokinetics, tolerability, and renal and haemodynamic effects of BG 9928 in patients with congestive heart failure.

Trial Profile

Pharmacokinetics, tolerability, and renal and haemodynamic effects of BG 9928 in patients with congestive heart failure.

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Jan 2011

At a glance

  • Drugs Tonapofylline (Primary)
  • Indications Heart failure
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 12 Jan 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top